Viewing Study NCT01393756


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-01-05 @ 11:59 AM
Study NCT ID: NCT01393756
Status: COMPLETED
Last Update Posted: 2023-12-05
First Post: 2011-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
Sponsor:
Organization: